Suchergebnisse - "O'Day, Steven J"

PubPharm (17)

1

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

enthalten in: Journal for ImmunoTherapy of Cancer | 2016

von Amin, A. | Lawson, D. | Salama, A. | +8

2

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

enthalten in: Journal for ImmunoTherapy of Cancer | 2016

von Amin, A. | Lawson, D. | Salama, A. | +8

3

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

enthalten in: Journal for immunotherapy of cancer | 2016

von Amin, A. | Lawson, D. | Salama, A. | +8

4

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002) : a randomised, controlled, phase 2 trial

enthalten in: The Lancet. Oncology | 2015

von Ribas, A. | Puzanov, I. | Dummer, R. | +33

CommentIn: Lancet Oncol. 2015 Aug;16(8):873-4. - PMID 26115798

5

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

enthalten in: Journal of translational medicine | 2015

von Dummer, R. | Daud, A. | Puzanov, I. | +18

6

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

enthalten in: Journal of translational medicine | 2015

von Dummer, R. | Daud, A. | Puzanov, I. | +18

7

Development of ipilimumab : a novel immunotherapeutic approach for the treatment of advanced melanoma

enthalten in: Annals of the New York Academy of Sciences | 2013

von Wolchok, J. | Hodi, F. | Weber, J. | +9

8

Safety and clinical activity of ipilimumab in melanoma patients with brain metastases : retrospective analysis of data from a phase 2 trial

enthalten in: Melanoma research | 2011

von Weber, J. | Amin, A. | Minor, D. | +3

9

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

enthalten in: Investigational new drugs | 2011

von Hersh, E. | O'Day, S. | Powderly, J. | +7

10

Ipilimumab efficacy and safety in patients with advanced melanoma : a retrospective analysis of HLA subtype from four trials

enthalten in: Cancer immunity | 2010

von Wolchok, J. | Weber, J. | Hamid, O. | +9

CommentIn: Immunotherapy. 2011 May;3(5):595-9. - PMID 21554088